L1CA34 Stock Overview
Provides laboratory services. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Labcorp Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$362.16 |
| 52 Week High | US$362.16 |
| 52 Week Low | US$250.00 |
| Beta | 1.11 |
| 1 Month Change | 0.52% |
| 3 Month Change | n/a |
| 1 Year Change | 38.74% |
| 3 Year Change | 5.34% |
| 5 Year Change | 166.59% |
| Change since IPO | 93.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| L1CA34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0% | 1.1% | 2.1% |
| 1Y | 38.7% | -14.4% | -5.5% |
Return vs Industry: L1CA34 exceeded the BR Healthcare industry which returned -14.4% over the past year.
Return vs Market: L1CA34 exceeded the BR Market which returned -5.5% over the past year.
Price Volatility
| L1CA34 volatility | |
|---|---|
| L1CA34 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in BR Market | 9.5% |
| 10% least volatile stocks in BR Market | 3.0% |
Stable Share Price: L1CA34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine L1CA34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 65,450 | Adam Schechter | www.labcorp.com |
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Labcorp Holdings Inc. Fundamentals Summary
| L1CA34 fundamental statistics | |
|---|---|
| Market cap | R$115.17b |
| Earnings (TTM) | R$4.29b |
| Revenue (TTM) | R$74.73b |
26.9x
P/E Ratio1.5x
P/S RatioIs L1CA34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L1CA34 income statement (TTM) | |
|---|---|
| Revenue | US$13.01b |
| Cost of Revenue | US$9.38b |
| Gross Profit | US$3.62b |
| Other Expenses | US$2.88b |
| Earnings | US$746.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.91 |
| Gross Margin | 27.86% |
| Net Profit Margin | 5.73% |
| Debt/Equity Ratio | 79.4% |
How did L1CA34 perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield32%
Payout RatioDoes L1CA34 pay a reliable dividends?
See L1CA34 dividend history and benchmarks| Labcorp Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Feb 26 2025 |
| Dividend Pay Date | Mar 18 2025 |
| Days until Ex dividend | 19 days |
| Days until Dividend pay date | 1 day |
Does L1CA34 pay a reliable dividends?
See L1CA34 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/15 15:23 |
| End of Day Share Price | 2025/02/24 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Labcorp Holdings Inc. is covered by 49 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Brian Kemp Dolliver | Avondale Partners |
| Eric Coldwell | Baird |